US Stock MarketDetailed Quotes

NUVL Nuvalent

Watchlist
  • 84.220
  • -0.420-0.50%
Close Dec 20 16:00 ET
  • 84.220
  • 0.0000.00%
Post 20:01 ET
5.98BMarket Cap-24.13P/E (TTM)

About Nuvalent Company

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.

Company Profile

SymbolNUVL
Company NameNuvalent
Listing DateJul 29, 2021
Issue Price17.00
Founded2017
CEODr. James R. Porter, PhD
MarketNASDAQ
Employees92
Fiscal Year Ends12-31
AddressOne Broadway,14th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-857-357-7000
Websitehttp://www.nuvalent.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Matthew Shair, PhD
  • Director, Scientific Founder and Head Scientific Advisor
  • 688.18K
  • Dr. James R. Porter, PhD
  • Director, Chief Executive Officer and President
  • 9.38M
  • Darlene Noci, A.C.I.S.
  • Chief Development Officer
  • --
  • Dr. Christopher D. Turner, M.D.
  • Chief Medical Officer
  • 3.60M
  • Alexandra Balcom, M.B.A.
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 3.54M
  • Dr. Deborah Miller, J.D.,PhD
  • Chief Legal Officer and Secretary
  • --
  • Dr. Emily Drabant Conley, PhD
  • Independent Director
  • 495.90K
  • Dr. Cameron A. Wheeler, PhD
  • Independent Director
  • 499.45K
  • Grant Bogle
  • Independent Director
  • --
  • Dr. Joseph Pearlberg, M.D.,PhD
  • Independent Director
  • 494.00K
  • Anna Protopapas
  • Independent Director
  • 523.18K
  • Dr. Sapna Srivastava, PhD
  • Independent Director
  • 503.18K
  • Dr. D. Gary Gilliland, M.D.,PhD
  • Independent Director
  • 495.68K
  • Dr. Andrew A. F. Hack, M.D.,PhD
  • Independent Director
  • 495.68K
  • Dr. Michael L. Meyers, M.D.,PhD
  • Independent Director
  • 494.36K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List